Question 1
1 out of 1 points
A 51-year-old female patient has been receiving doxorubicin (Adriamycin) for
metastatic breast cancer. Her medical record indicates she has cardiomyopathy and
a cumulative dose of 300 m
...
Question 1
1 out of 1 points
A 51-year-old female patient has been receiving doxorubicin (Adriamycin) for
metastatic breast cancer. Her medical record indicates she has cardiomyopathy and
a cumulative dose of 300 mg/m2 of doxorubicin. Which of the following measures
would help limit the severity of the cardiomyopathy in this patient?
Response
Feedback
:
Dexrazoxane, a cardioprotectant, is recommended to reduce the
severity and incidence of cardiomyopathy associated with doxorubicin
for women with metastatic breast cancer who received a cumulative
dose of 300 mg/m2
. Meticulous monitoring or multiplying daily doses
would not reduce the severity and incidence of cardiomyopathy as
effectively as using dexrazoxane, and reducing the dosage is not
advisable.
Question 2
1 out of 1 points
A patient is pregnant and is at 7 weeks' gestation. She has type 1 diabetes and has
been taking insulin since she was 13 years old. She asks the nurse if the insulin will
be harmful to her baby. The best response to the patient by the nurse would be
Response
Feedback
:
The best response would be to tell the patient that insulin is the drug of
choice because it does not cross the placenta and reach the fetus.
Hyperglycemia is not associated with low birth weight. Telling the
patient's physician is also appropriate; however, the nurse can offer
information that can immediately allay the patient's concern.
Question 3
1 out of 1 points
A nurse is performing patient education for a woman who has just been prescribed a
bisphosphonate. Which of the following diagnostic and history findings would have
[Show More]